Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Abrdn Physical Platinum Shares ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Abrdn Physical Platinum Shares ETF trades at $14.77. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | PPLT | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $25.23 |
52-Week Low | $23.09 | $11.78 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PPLT trades at $14.77, up 1.03% with a bearish technical outlook as moving averages signal selling pressure. The ETF recently completed a 10-for-1 stock split effective May 2026, maintaining the same total value per shareholder. News coverage highlights platinum's underperformance relative to gold and silver, with Seeking Alpha downgrading the ETF to 'Hold' in May 2026 after substantial gains.
The outlook remains cautious as technical indicators show bearish momentum despite neutral oscillators. Platinum's lag in the precious metals rally presents potential catch-up opportunity, but current valuation lacks clear fundamental catalysts. Key risks include commodity price volatility and dependence on industrial demand cycles.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →